Naropin

Fresenius Kabi USA, LLC🇺🇸 United States

FDA Page

Effective Date: Feb 13, 2024
Approval ID: 23d2d448-a744-4877-9f2d-7e57c198da89
Products: 4 registered
Version: 25

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NAROPIN safely and effectively. See full prescribing information for NAROPIN. NAROPIN (ropivacaine hydrochloride) injection, for epidural, perineural, or infiltration useInitial U.S. Approval: 1996 Rx Only

Quick Stats

Total Products4

Labelers2

Label Sections73

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.